SCHEMBL13984047

SCHEMBL13984047

C=C(c1ccc(Cl)cc1)c1ccc(OC(C)(C)C(=O)NC(CC)(CON(O)O)CON(O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 8/20 0.43
▸ CYP1A2 P05177 3/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ FABP2 P12104 2/20 0.42
▸ PPARG P37231 2/20 0.42
▸ SLC22A12 Q96S37 1/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CNR1 P21554 8/20 0.41
▸ CNR2 P34972 5/20 0.41
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13984041 0.95 PPARA (0.45) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL12634588 0.86 PPARA (0.55) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL13983712 0.82 ALDH1A1 (0.45) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL13983873 0.78 PPARA (0.53) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL13983835 0.76 PPARA (0.56) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL13983696 0.76 PPARA (0.56) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL13983707 0.74 PPARA (0.53) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL13983688 0.73 PPARA (0.53) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL13983691 0.73 PPARA (0.53) PPARACYP1A2CYP3A4FABP2PPARG
SCHEMBL12635844 0.73 PPARA (0.53) PPARACYP1A2CYP3A4FABP2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008157537-A2 COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS IRONWOOD PHARMACEUTICALS, INC (US) 2008-12-24 — — WO disclosed
Send feedback